|
Aug 29
|
Expensive Drugs Targeted for First U.S. Price Negotiations
|
|
Aug 29
|
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Merck, Novartis and AstraZeneca
|
|
Aug 29
|
Biden Administration targets drugs from J&J, Merck for controversial Medicare price negotiations
|
|
Aug 28
|
Oncology Market's Huge Potential Puts These Stocks in Focus
|
|
Aug 26
|
Ken Fisher’s Top 15 Healthcare Stock Picks
|
|
Aug 25
|
AstraZeneca sues US over drug pricing laws
|
|
Aug 25
|
Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases
|
|
Aug 25
|
AstraZeneca becomes first international company to file Medicare drug pricing suit
|
|
Aug 25
|
AstraZeneca's (AZN) Lynparza Gets Expanded Use Nod in Japan
|
|
Aug 25
|
AstraZeneca files lawsuit against U.S. over drug pricing
|
|
Aug 25
|
AstraZeneca sues US government over drug price reforms
|
|
Aug 25
|
Pharma Stock Roundup: PFE Gets Nod for RSV Vaccine, J&J Finalizes Kenvue Separation
|
|
Aug 25
|
Midday movers: Affirm, Gap, Marvell Technology and more
|
|
Aug 25
|
AstraZeneca sues US over Medicare drug price negotiation plans
|
|
Aug 25
|
UPDATE 3-AstraZeneca sues US over Medicare drug price negotiation plans
|